Clinical research changes quickly.
Keep up-to-date with our help!
2012 Articles
Myeloperoxidase
Karakas M et al.
Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: Results from the MONICA/KORA Augsburg study. J Intern Med. 2012; 271:43-50
Abstract2011 Articles
Myeloperoxidase
Oemrawsingh RM et al.
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome. Heart. 2011. Epub ahead of print.
Abstract
Ndrepepa G et al.
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.
Clin Res Cardiol. 2011; 100: 327-333.
Abstract
Tang WHW et al.
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. Clin Chem. 2011; 57: 33-39.
Abstract
High-density lipoprotein (HDL)
Khera AV et al.
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364: 127-135.
Abstract
F2-Isoprostanes
Davies SS and Roberts LJ 2nd.
F2-Isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med. 2011; 50: 559-566.
Abstract
Vitamin D
Rosen CJ.
Vitamin D insufficiency.
N Engl J Med. 2011; 364: 248-254.
Abstract
Guidelines for CVD and Diabetes
Mosca L et al.
Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update. Circulation. 2011; 123: 1243-1262.
Abstract
American Diabetes Association.
Standards of Medical Care in Diabetes-2011. Diabetes Care. 2011; 34 (Supplement 1): S11-S61.
Abstract